Quality Assurance Lead
Telix Pharmaceuticals (Americas)
Summary
The Quality Assurance Lead role is a site-based role located in Wilkes-Barre, Pennsylvania, reporting to the Quality Director, Manufacturing Expansion & Readiness, with operational relationship to site leadership. The role will coordinate and support Quality Assurance processes and activities for clinical supply in accordance with applicable cGMP requirements. It will also support the preparation and review of CMC sections for CTA/IND and Marketing Authorization submissions for new product development.
Job description
As part of the Telix Manufacturing Solution (TMS) network, this position will provide site-level Quality expertise and implementation support during commissioning, qualification, validation, and operational readiness of the Wilkes-Barre facility. The role will support the implementation and maintenance of Quality Systems, procedures, processes, documentation, training, and oversight activities required to transition the site from project execution to routine GMP operations.
Key Accountabilities
Quality Systems and Compliance
- Maintain assigned elements of the site QMS and eQMS, including MasterControl.
- Prepare, review, and maintain controlled Quality documentation.
- Identify compliance gaps and support implementation of corrective actions and process improvements.
Quality Events and Risk Management
- Coordinate and support deviations, investigations, CAPAs, change controls, complaints, and Quality risk assessments.
- Lead assigned investigations within delegated authority and escalate significant product quality or compliance risks.
Training, Audits, and Inspection Readiness
- Coordinate Quality training activities and maintain associated training records and matrices.
- Support internal audits, external audits, and regulatory inspections, including preparation and follow-up activities.
- Help maintain site inspection readiness through proactive identification and remediation of compliance gaps.
Supplier and Operational Quality
- Support supplier qualification, Quality Agreements, vendor oversight, and external-provider audits.
- Provide site-level Quality support for manufacturing, QC, supply chain, validation, and outsourced activities.
- Review validation documentation, manufacturing records, and QC data within delegated authority.
Batch Review and Continuous Improvement
- Perform or support batch-record review and product-release activities in accordance with approved procedures and delegated authority.
- Monitor assigned Quality metrics and recommend improvements to compliance, process effectiveness, and operational readiness.
Requirements
- Bachelor's degree in pharmacy, biochemistry, life sciences, or related scientific discipline highly preferred
- 5 years of progressive Quality Assurance experience in pharmaceutical, biotechnology, or similarly regulated environment
- Working knowledge of 21 CFR Parts 210 and 211, cGMP requirements, and pharmaceutical quality systems
- Experience supporting deviations, investigations, CAPAs, change controls, internal audits, supplier quality, and validation-document review
- Experience supporting commissioning, qualification, validation, or operational readiness of a manufacturing facility preferred
- Experience using an electronic QMS, preferably MasterControl
- Ability to work independently within established procedures and escalate significant compliance risks appropriately
Benefits
- Competitive Salaries
- Annual Performance-Based Bonuses
- Equity-Based Incentive Program
- Generous Vacation
- Paid Wellness Days
- Learning & Development Support
Company overview
Telix Pharmaceuticals (Americas) is the United States operations division of Telix Pharmaceuticals Limited, a global commercial-stage biopharmaceutical company specializing in the development and commercialization of therapeutic and diagnostic radiopharmaceuticals, commonly known as 'theranostics'. Headquartered in Melbourne, Australia with global operations spanning the United States, Europe, and Japan, Telix focuses on precision oncology through targeted radiation therapies. The company's innovative pipeline addresses significant unmet medical needs in urologic oncology (prostate and kidney cancer), neuro-oncology (glioma), musculoskeletal oncology (sarcoma), and bone marrow conditioning. Telix has achieved regulatory approvals from the FDA, TGA, and Health Canada for its prostate cancer imaging agent Illuccix®, and maintains an extensive portfolio of over 18 clinical trials worldwide. As a dynamic, fast-growing radiopharmaceutical company, Telix Pharmaceuticals (Americas) plays a crucial role in the international rollout of approved products and advancement of late clinical-stage therapies, leveraging a global workforce of 1,000-5,000 employees dedicated to improving quality of life for cancer patients through targeted radiation solutions.